PER-021-02已完成未知
A Double-Blind, Multicenter, Placebo and Active-Controlled, Acute Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2002年2月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •*Male or female patients who need treatment with antidepressant medications.
- •*Over 18 years of age.
排除标准
- •* Women who are pregnant or breastfeeding or intend to
- •get pregnant in the next 12 months
- •* Contraindication or history of hypersensitivity to paroxetine hydrochloride.
研究者
相似试验
进行中（未招募）
1 期
A Multicenter, Double-Blind, Placebo and Active-Controlled, Parallel Group Study to Compare the Efficacy and Safety of Oral MK-0974 With Placebo and Zolmitriptan for the Acute Treatment of Migraine With or Without Aura - MK-0974 Pivotal Study 1 - worldwide (with active comparator)MigraineEUCTR2006-004257-14-GBMerck Sharp & Dohme Limited1,800
进行中（未招募）
1 期
A Multicenter, Double-Blind, Placebo and Active-Controlled, Parallel Group Study to Compare the Efficacy and Safety of Oral MK-0974 With Placebo and Zolmitriptan for the Acute Treatment of Migraine With or Without Aura - MK-0974 Pivotal Study 1 - worldwide (with active comparator)MigraineEUCTR2006-004257-14-NLMerck Sharp & Dohme (MSD)1,800
进行中（未招募）
不适用
A Multicenter, Double-Blind, Placebo and Active Controlled, Randomized Study toEvaluate the Safety and Efficacy of the Addition of Sitagliptin 100mg Once Daily inPatients with Type 2 Diabetes With Inadequate Glycemic Control on MetforminMonotherapy - Sitagliptin 100mg in Patients With Type 2 Diabetes With Inadequate Glycemic ControlEUCTR2006-001335-22-SEMerck Sharp & Dohme (Sweden) AB270
进行中（未招募）
不适用
A Multicenter, Double-Blind, Placebo and Active Controlled, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin 100mg Once Daily in Patients with Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy - NDType 2 Diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentEUCTR2006-001335-22-ITMERCK SHARP DOHME270
进行中（未招募）
不适用
A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexibly-Dosed Quetiapine and Placebo in the Treatment of Acute Manic and Mixed Episodes Associated with Bipolar I Disorder - Protocol R076477-BIM-3002 Phase 3Bipolar I DisorderEUCTR2005-005812-25-LTJanssen-Cilag International N.V.475